This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified site user
Data security
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Services
Translation, Interpreting, Editing/proofreading
Expertise
Specializes in:
Management
Finance (general)
Law: Contract(s)
Business/Commerce (general)
Accounting
Agriculture
Certificates, Diplomas, Licenses, CVs
Medical: Cardiology
Medical: Pharmaceuticals
Medical: Instruments
Also works in:
Government / Politics
Human Resources
History
Social Science, Sociology, Ethics, etc.
Medical: Health Care
Medical (general)
Manufacturing
More
Less
Rates
English to Spanish - Rates: 0.08 - 0.15 USD per word / 25 - 50 USD per hour
All accepted currencies
U. S. dollars (usd)
Blue Board entries made by this user
0 entries
Payment methods accepted
Check, Money order
Portfolio
Sample translations submitted: 1
English to Spanish: TITLE: A Dose-regimen Finding Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics and Activity of xxxx in Subjects with Advanced Malignancies (xxxxxxxx) General field: Medical Detailed field: Medical: Health Care
Source text - English PRINCIPAL INVESTIGATOR xxxxxx, MD, PhD
STUDY NO.: xxxxxxx
Consent Form Given to Patient Taking Part in an Investigational/Clinical Research Study
This is a clinical research study. Clinical research studies include only those patients who choose to take part. Please take your time to make your decision. Discuss it with your family and with people who are important to you.
We invite you to take part in a clinical research/investigational study for patients with an advanced stage xxxxxx. It has been explained to you that your xxxx is no longer responding to usual treatment and you are being offered a drug that is considered investigational.
It is important that you read and understand several general rules that apply to anyone that takes part in our studies:
1. This study is considered research. It is investigational.
2. Taking part in the study is voluntary.
3. You may withdraw from the study at any time without penalty, loss of any benefits or access to care at xxxxx to which you are otherwise entitled.
4. If you should decide not to take part in this study, it will not affect your care at xxxxx xxxxx xxxxxx now or in the future.
5. You should feel free to get a second opinion. This will not affect your ability to receive care and treatment here if you get one.
6. Your disease may not be helped from taking part in this study, but we may get information that could help others.
7. If we become aware of important new findings that relate to your participation or continued participation in this study we will discuss them with you.
The type of study, the risks, benefits, discomforts, and other important information about this study are discussed below.
1. INTRODUCTION:
xxxxxxxxx, Inc. is testing an oral combination drug treatment, xxxx with xxxxx-xx (xxxxx) which allows for intestinal absorption of xxxxxx at therapeutic levels. xxxx is a research combination drug of xxxxxx-xx and xxxxxx and is not approved for marketing.
Your doctor has decided that xxxxx may be the best treatment option available to you at this time. xxxxx is a combination of xxxxxxx-xx (one (1) 15 mg tablet) and xxxxxx dose levels of xxxxxxx mg/m². xxxxx is an approved chemotherapeutic agent to be injected into veins; however, this study is attempting to deliver xxxxx orally. You will be provided with xx mg capsules of xxxxx and you will be instructed how many capsules to take depending on your dose level.
Formulario de Consentimiento Dado al Paciente que Participa en un Estudio de Investigación Clínica
Este es un estudio de investigación clínica. Los estudios de investigación clínica incluyen solo a los pacientes que eligen participar. Por favor tómese tiempo para tomar su decisión. Discútalo con su familia y con personas que son importantes para usted.
Lo invitamos a participar en un estudio de investigación clínica para pacientes con un xxxx sólido en etapa avanzada. Se le ha explicado que su xxxxx ya no responde al tratamiento usual y se le ofrece un medicamento que se considera de investigación.
Es importante que lea y comprenda varias reglas generales que se aplican a cualquiera que participe en nuestros estudios:
1. Este estudio se considera que es de investigación.
2. Tomar parte en el estudio es voluntario.
3. Puede retirarse del estudio en cualquier momento sin penalización, pérdida de beneficios o acceso a la atención en xxxx a la que tiene derecho.
4. Si decide no participar en este estudio, no afectará su cuidado en el xxxxxx ahora o en el futuro.
5. Debe sentirse con libertad de obtener una segunda opinión. Esto no afectará su capacidad de recibir atención y tratamiento aquí si obtiene otra opinión.
6. Es posible que no ayude a su enfermedad al participar en este estudio, pero nosotros podríamos obtener información que pueda ayudar a otros.
7. Si nos damos cuenta de nuevos hallazgos importantes que se relacionan con su participación o participación continuada en este estudio, los discutiremos con usted.
El tipo de estudio, los riesgos, beneficios, incomodidades y otra información importante acerca de este estudio se discuten a continuación.
1. INTRODUCCIÓN:
xxxxxx, Inc. está probando un tratamiento farmacológico de combinación oral, xxxx con xxxxxx-xx (xxxx) que permite la absorción intestinal de xxxxx a niveles terapéuticos. xxxxx es un fármaco de combinación de investigación de xxxxxxx y xxxxxx y no está aprobado para comercialización.
Su médico ha decidido que xxxx puede ser la mejor opción de tratamiento disponible para usted en este momento. xxxxx es una combinación de xxxxxxx-xx (una (1) tableta de 15 mg) y niveles de dosis de xxxxxx de xxxxxx mg / m². xxxxxx es un agente quimioterapéutico aprobado para inyectarse en las venas; sin embargo, este estudio intenta administrar xxxxxx por vía oral. Se le proporcionarán a usted cápsulas de xxx mg de xxxxxx y se le indicará cuántas cápsulas puede tomar según su nivel de dosis.
More
Less
Translation education
Master's degree - Texas A&I University
Experience
Years of experience: 9. Registered at ProZ.com: Dec 2015.
My Passion is getting translations right the
first time!
I was born
in Mexico, grew up and educated in the United States. My translation and interpretation background
started when I was in the third grade. My
father gave me a book and I started reading it fluently, never having had a
lesson in Spanish. I was his interpreter
and translator from that day on. I retired from industry after 38 years while always
loving to translate and interpret for my employers. My professional T and I career started 5 years
ago. All of my projects have been on
time. I also tutor recent immigrants from their
native language into English at nights.
Expertise 
